|
|
 |
|
Viewing report
|
|
 |
 |
Pediatric Drugs and Vaccines - Global Strategic Business Report
Global Industry Analysts, Inc, April 2011, Pages: 1,088
This report analyzes the worldwide markets for Pediatric Drugs and Vaccines in US$ Million by the following Product Segments: Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs, and Other Pediatric Drugs. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 159 companies including many key and niche players such as Abbott Laboratories, Allergan, Inc., Amgen, Inc., AstraZeneca Plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann–La Roche Ltd., Genentech, Inc., GlaxoSmithKline Plc, Merck & Co., Inc., Merck Serono, Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi-Aventis, Shionogi, Inc., Shire Pharmaceuticals Group Plc, and UCB Pharma. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
|
 |
|
|